Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 7.36% is 177% above its 5-year average of 2.66%, around the middle of its 5-year range (-11.18%–19.99%).
769.09% above its 12-month average of -1.10%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): 1.26%.
RETURN ON ASSETS (ROA)
7.36%
RETURN ON ASSETS (ROA) AVG TTM
-1.10%
RETURN ON ASSETS (ROA) AVG 3Y
-3.18%
RETURN ON ASSETS (ROA) AVG 5Y
2.66%
RETURN ON ASSETS (ROA) AVG 10Y
-10.01%
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+769.09%
CURRENT VS 3Y AVG
+331.63%
CURRENT VS 5Y AVG
+176.52%
CURRENT VS 10Y AVG
+173.56%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.24%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+122.83%
vs the sector median at left
The Joint Corp.
Market Cap
$101.28M
Return on Assets (ROA)
7.36%
TTM Avg
-1.10%
3Y Avg
-3.18%
5Y Avg
2.66%
Market Cap
$102.92M
Return on Assets (ROA)
-69.14%
TTM Avg
-63.05%
3Y Avg
-52.31%
5Y Avg
-58.69%
Market Cap
$103.68M
Return on Assets (ROA)
-57.98%
TTM Avg
-386.38%
3Y Avg
-312.00%
5Y Avg
-312.00%
Market Cap
$104.00M
Return on Assets (ROA)
-34.04%
TTM Avg
-20.59%
3Y Avg
-37.88%
5Y Avg
-37.10%
Market Cap
$104.21M
Return on Assets (ROA)
-33.85%
TTM Avg
-28.41%
3Y Avg
-17.06%
5Y Avg
-12.28%
Market Cap
$98.41M
Return on Assets (ROA)
-32.73%
TTM Avg
-70.83%
3Y Avg
-106.23%
5Y Avg
-81.00%
Market Cap
$97.52M
Return on Assets (ROA)
-206.78%
TTM Avg
-134.13%
3Y Avg
-143.93%
5Y Avg
-119.05%
Market Cap
$97.64M
Return on Assets (ROA)
-65.25%
TTM Avg
-70.13%
3Y Avg
-63.89%
5Y Avg
-46.24%
Market Cap
$106.18M
Return on Assets (ROA)
-70.09%
TTM Avg
-324.97%
3Y Avg
-229.15%
5Y Avg
-168.27%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| The Joint Corp. (JYNT) | $101.28M | 7.36% | -1.10% | -3.18% | 2.66% |
| Anixa Biosciences, Inc. (ANIX)vs › | $102.92M | -69.14% | -63.05% | -52.31% | -58.69% |
| Polaryx Therapeutics, Inc. Common Stock (PLYX)vs › | $103.68M | -57.98% | -386.38% | -312.00% | -312.00% |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $104.00M | -34.04% | -20.59% | -37.88% | -37.10% |
| Definitive Healthcare Corp. (DH)vs › | $104.21M | -33.85% | -28.41% | -17.06% | -12.28% |
| OnKure Therapeutics, Inc. (OKUR)vs › | $98.41M | -32.73% | -70.83% | -106.23% | -81.00% |
| PolyPid Ltd. (PYPD)vs › | $97.52M | -206.78% | -134.13% | -143.93% | -119.05% |
| Korro Bio, Inc. (KRRO)vs › | $97.64M | -65.25% | -70.13% | -63.89% | -46.24% |
| Immunic, Inc. (IMUX)vs › | $106.18M | -70.09% | -324.97% | -229.15% | -168.27% |
| Park Dental Partners, Inc. Common Stock (PARK)vs › | $96.58M | -1.90% | 1.32% | 1.93% | 1.93% |
ROA
7.4%
ROE
24.0%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 4.77% |
| 2024-12-31 | -6.97% |
| 2023-12-31 | -11.18% |
| 2022-12-31 | 0.67% |
| 2021-12-31 | 8.69% |
| 2020-12-31 | 19.99% |
| 2019-12-31 | 7.60% |
| 2018-12-31 | 1.08% |
| 2017-12-31 | -19.37% |
| 2016-12-31 | -88.97% |
| 2015-12-31 | -26.37% |
| 2014-12-31 | -10.61% |
| 2013-12-31 | 1.59% |
| 2012-12-31 | -8.09% |
